<abstract xmlns="http://www.w3.org/1999/xhtml"><p> Introduction: The use of BtA in spasticity management is well documented in the literature for the management of hypertonicity in children with cerebral palsy. Methods: We report a case of a 2-year-old boy with severe haemophilia and cerebral palsy who received intramuscular injections of botulinum toxin-A (BtA) to reduce his spastic diplegia lower limb hypertonicity. Results: Following treatment, clinical and formal assessments demonstrated positive changes in ambulation, tolerance of orthotics, functional abilities and musculoskeletal range of movement and no adverse bleeding side effects. Conclusion: The use of BtA should be considered for the management of hypertonicity in children with haemophilia and cerebral palsy.</p></abstract>

Introduction: The use of BtA in spasticity management is well documented in the literature for the management of hypertonicity in children with cerebral palsy. Methods: We report a case of a 2-year-old boy with severe haemophilia and cerebral palsy who received intramuscular injections of botulinum toxin-A (BtA) to reduce his spastic diplegia lower limb hypertonicity. Results: Following treatment, clinical and formal assessments demonstrated positive changes in ambulation, tolerance of orthotics, functional abilities and musculoskeletal range of movement and no adverse bleeding side effects. Conclusion: The use of BtA should be considered for the management of hypertonicity in children with haemophilia and cerebral palsy.

IM botulinum toxin-A improves ambulation in severe haemophilia and cerebral palsy

The Journal of Haemophilia Practice

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.

Introduction: The use of BtA in spasticity management is well documented in the literature for the management of hypertonicity in children with cerebral palsy....

IM botulinum toxin-A improves ambulation in severe haemophilia and cerebral palsy

Article Category: Clinical Research

Data publikacji: 21 kwi 2018

Zakres stron: 21 - 23

DOI: https://doi.org/10.17225/jhp.00020

Słowa kluczowe
haemophilia, cerebral palsy, botulinum toxin-A

© 2018

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.

IM botulinum toxin-A improves ambulation in severe haemophilia and cerebral palsy

Article Category: Clinical Research

Data publikacji: 21 kwi 2018

Zakres stron: 21 - 23

DOI: https://doi.org/10.17225/jhp.00020

Słowa kluczowehaemophilia, cerebral palsy, botulinum toxin-A

© 2018

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.

Słowa kluczowe
haemophilia, cerebral palsy, botulinum toxin-A